News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,949 Results
Type
Article (219)
Company Profile (1)
Press Release (1729)
Section
Business (677)
Career Advice (1)
Deals (124)
Drug Delivery (7)
Drug Development (106)
FDA (17)
Job Trends (27)
News (916)
Policy (98)
Tag
Academia (3)
Alliances (223)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (6)
Approvals (18)
Autoimmune disease (6)
Best Places to Work (12)
BIOSECURE Act (18)
Biotechnology (1)
Cancer (8)
Cardiovascular disease (1)
Career advice (1)
CAR-T (3)
Cell therapy (11)
Clinical research (90)
Collaboration (14)
COVID-19 (8)
C-suite (3)
Data (10)
Diagnostics (16)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (190)
Editorial (1)
Events (160)
Executive appointments (6)
FDA (20)
Funding (5)
Gene therapy (1)
GLP-1 (8)
Government (27)
Healthcare (26)
Immunology and inflammation (3)
Immuno-oncology (1)
Infectious disease (8)
Inflammatory bowel disease (1)
Intellectual property (2)
IPO (63)
IRA (1)
Job creations (13)
Job search strategy (1)
JPM (1)
Layoffs (3)
Legal (9)
Lung cancer (1)
Manufacturing (32)
MASH (1)
Medical device (18)
Medtech (18)
Mergers & acquisitions (66)
Metabolic disorders (5)
Multiple sclerosis (4)
NASH (1)
Neuroscience (6)
NextGen: Class of 2026 (17)
Non-profit (2)
Obesity (3)
Opinion (5)
People (169)
Phase 1 (58)
Phase 2 (36)
Phase 3 (13)
Pipeline (28)
Policy (23)
Preclinical (11)
Radiopharmaceuticals (1)
Real estate (63)
Regulatory (74)
Reports (1)
Research institute (1)
Series A (1)
Series B (1)
Startups (38)
Supply chain (4)
Tariffs (1)
The Weekly (4)
Vaccines (2)
Venture capital (1)
Weight loss (2)
Date
Last 7 days (2)
Last 30 days (13)
Last 365 days (96)
2026 (16)
2025 (93)
2024 (128)
2023 (113)
2022 (217)
2021 (205)
2020 (159)
2019 (117)
2018 (135)
2017 (118)
2016 (97)
2015 (117)
2014 (65)
2013 (60)
2012 (43)
2011 (38)
2010 (48)
Location
Africa (2)
Asia (963)
Australia (13)
California (26)
Canada (2)
China (65)
Europe (148)
Florida (3)
Illinois (1)
India (2)
Japan (1)
Maryland (1)
Massachusetts (17)
New Jersey (19)
New York (1)
North Carolina (1)
Northern California (17)
Ohio (2)
Pennsylvania (4)
South America (1)
Southern California (5)
Texas (1)
United States (77)
Utah (1)
Washington D.C. (3)
1,949 Results for "wuxi apptec".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition in the CRDMO Industry
November 20, 2025
·
5 min read
Press Releases
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health
October 28, 2025
·
3 min read
Press Releases
WuXi AppTec Completes Second RMB1.0 Billion A-Share Repurchase Program in 2025, All Repurchased Shares to Be Cancelled
August 28, 2025
·
1 min read
Press Releases
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance
October 27, 2025
·
22 min read
BIOSECURE Act
WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms
With the BIOSECURE Act likely to be voted on in Congress this year, WuXi AppTec’s U.S. revenue dropped 1.2% in the first half of 2024 while the Chinese company increased its lobbying efforts.
July 29, 2024
·
2 min read
·
Tyler Patchen
Press Releases
NAMSA Completes Acquisition of WuXi AppTec US Medical Device Testing Business
March 4, 2025
·
2 min read
Press Releases
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)
January 13, 2025
·
2 min read
Policy
BIO Separates from China’s WuXi AppTec Amid National Security Concerns
In a change of position as congressional scrutiny of WuXi AppTec grows, the Biotechnology Innovation Organization announced it is taking steps to separate from the China-based biotech.
March 14, 2024
·
3 min read
·
Tristan Manalac
Press Releases
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
February 3, 2026
·
2 min read
Policy
WuXi AppTec Shared Client IP with Beijing, Say US Intelligence Officials: Reuters
U.S. intelligence officials have informed senators that China-based biotech WuXi AppTec transferred an American client’s intellectual property to the Chinese government without consent, reports Reuters.
March 29, 2024
·
2 min read
·
Tristan Manalac
1 of 195
Next
